InvestorsHub Logo
Followers 91
Posts 11554
Boards Moderated 0
Alias Born 06/06/2014

Re: stockaesthetics post# 76570

Thursday, 09/29/2016 2:50:23 PM

Thursday, September 29, 2016 2:50:23 PM

Post# of 471509
From our February 2016 study presentation on the company website we can see 2-73 has been successfully tested in vitro for protecting OLs & OPCs against known cyto-toxins. So I guess Biogen now wants to see if 2-73 can help induce OPCs to turn into OLs ("differentiate") in a lab dish, and if so, then see if it can do it in mice and result in a therapeutic effect: remyelination.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News